-
-
Changes to Medicare's Important Message (IM), informing patients of their rights to Medicare services and to question discharge decisions, which went into effect in July 2007, coincided with a revamping of the hospital-issued notices of noncoverage (HINNs) that notify patients of their financial responsibility if they receive services not covered by Medicare.
-
Medicare's Important Message (IM) has been around for years, but a change to the rule and the process for imparting the IM has thrown many in discharge planning for a loop.
-
-
Kost and colleagues provide updated contraceptive failure rates derived from the 2002 National Survey of Family Growth.
-
-
In this issue: Rosiglitazone (Avandia) implicated in yet another study; Prilosec and Nexium not associated with cardiac events; Anastrozole (Arimidex) shown more effective than tamoxifen for treatment of early-stage breast cancer; antibiotics show no effect on sinusitis; FDA actions.
-
Years ago investigators attempted to use a form of progesteronedelalutinto prevent PTL. However, since there was no real proof of its benefit, progesterone was relegated to the "been there, done that" bin for many years until the concept was resurrected in the seminal paper published in 2003 by Meis et al.
-
In this Danish study, 415 women who had undergone hysterectomy between 1998 and 2000 responded to the same questionnaire related to incontinence both in September 2001 and also in January 2005.
-
Michels and colleagues from the Nurses' Health Study searched for a link between the incidence of breast cancer and either induced or spontaneous abortions in their prospective cohort of 105,716 women.
